Supreme Court Issues Controversial Ruling On Abortion Pill Access

The U.S. Supreme Court ruled Thursday that the abortion pill Mifepristone can continue being distributed by mail without requiring an in-person medical appointment, handing a significant victory to abortion-rights advocates and dealing a setback to pro-life states challenging the policy.

The decision temporarily blocks a recent ruling from the U.S. Court of Appeals for the Fifth Circuit that threatened to restrict nationwide access to the drug.

The Supreme Court granted emergency requests filed by drug manufacturers Danco Laboratories and GenBioPro seeking to halt enforcement of the lower court’s ruling while litigation continues.

The ruling ensures that access to the abortion pill will remain largely unchanged for now, including continued mail-order distribution policies implemented during the Biden administration.

Earlier this month, the Fifth Circuit Court of Appeals in New Orleans had ruled in favor of Louisiana’s challenge to federal rules allowing the drug to be prescribed remotely without in-person clinician visits.

On May 4, the Supreme Court — led procedurally by conservative Justice Samuel Alito — temporarily paused the appeals court ruling while the justices considered emergency motions filed by the manufacturers.

Ultimately, the high court sided with the drugmakers and blocked the restrictions from taking effect.

Conservative Justices Clarence Thomas and Alito dissented sharply from the ruling.

Justice Thomas argued that mailing mifepristone violates Louisiana law and criticized the pharmaceutical companies for seeking emergency protection from the court.

According to Thomas, the manufacturers were improperly attempting to shield “lost profits from their criminal enterprise.”

Justice Alito separately accused the Biden administration of using FDA policy changes to undermine the Supreme Court’s landmark 2022 ruling in Dobbs v. Jackson Women's Health Organization, which overturned Roe v. Wade.

“Louisiana’s efforts have been thwarted by certain medical providers, private organizations, and states that abhor laws like Louisiana’s and seek to undermine their enforcement,” Alito wrote.

Abortion-rights groups celebrated the decision as a temporary but important victory.

Alexis McGill Johnson praised the ruling in a public statement.

“The Supreme Court just did the bare minimum, but this ruling is a relief for patients who can continue to get the care they need. We know this is just one in a long line of attacks on our rights and our care,” Johnson said.

The underlying legal fight centers on a challenge brought by Louisiana against the Food and Drug Administration over policies adopted during the Biden administration that expanded remote access to mifepristone.

Those rules allowed abortion pills to be prescribed through telehealth appointments and shipped through the mail, including into states that heavily restrict or ban abortion.

Pro-life groups and Republican officials have argued that removing in-person safeguards creates serious health risks and undermines state abortion laws.

Louisiana Attorney General Liz Murrill argued in court filings that despite Louisiana’s near-total abortion ban, approximately 1,000 abortions per month were still occurring through mailed mifepristone pills entering the state.

After the ruling, Murrill criticized the Supreme Court’s decision.

“It’s shocking that the Supreme Court would block this common-sense return to medically ethical practices and oversight,” she said.

“We will keep fighting,” Murrill added.

Erin Hawley, representing the pro-life legal organization Alliance Defending Freedom, also condemned the ruling.

“It’s high time the Biden FDA be held accountable for the destruction it has caused with this high-risk drug,” Hawley said.

The decision comes during an especially active period for the Supreme Court, which earlier this week also handed Republicans a major victory involving congressional redistricting in Alabama.

In a separate 6-3 ruling, the justices allowed Alabama to move forward with efforts to redraw congressional maps that could strengthen Republican prospects in districts currently represented by Democrats Terri Sewell and Shomari Figures.

That ruling followed the Supreme Court’s recent decision in Louisiana v. Callais, which sharply limited race-based congressional redistricting practices.

Liberal Justices Sonia Sotomayor, Elena Kagan, and Ketanji Brown Jackson dissented in the Alabama case.